Skip to content
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Who We Serve
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees
About Us
Our Team
Our Story
Investment Strategies
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Private Wealth
Firefighters (FirefightersUnited™)
Police (911 Financial Services™)
Government Employees (911 Financial Services™)
Our Story
Our Team
Investment Strategies
Contact Us
Schwab Client Login
Contact Us
Schwab Client Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about XNAS:CRDL
Recent news which mentions XNAS:CRDL
Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients
June 17, 2024
Tickers
CRDL
CRDL
Tags
XNAS:CRDL
RazorPitch CRDL
From
TheNewswire.com - RSS (Media)
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development
June 11, 2024
Tickers
AZN
CRDL
NVO
SNY
Tags
XNYS:NVO
XNAS:AZN
XNAS:SNY
From
TheNewswire.com - RSS (Media)
Sector Spotlight: Orphan Drug Developers With Significant Upside
June 03, 2024
Tickers
CRDL
CRDL
KNSA
Tags
XNAS:CRDL
RazorPitch CRDL, KNSA
XNAS:KNSA
From
TheNewswire.com - RSS (Media)
Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases
October 13, 2023
Tickers
CRDL
Tags
XNAS:CRDL
Cardiol Therapeutics Inc
From
TheNewswire.com - RSS (Media)
Cardiol Therapeutics releases positive study results of subcutaneously administered cannabidiol
October 11, 2023
Tags
XNAS:CRDL
Cardiol Therapeutics
XTSE:CRDL
From
TheNewswire.com - RSS (Media)
Cardiol Therapeutics says first patient enrolled in Phase 2 study of CardiolRx for Pericarditis
January 17, 2023
Tags
XTSE:CRDL
XNAS:CRDL
Cardiol Therapeutics
From
TheNewswire.com - RSS (Media)
Cardiol Therapeutics begins Phase II study of CardiolRx for treatment of recurrent pericarditis
December 16, 2022
Tags
XTSE:CRDL
Cardiol Therapeutics
XNAS:CRDL
From
TheNewswire.com - RSS (Media)
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.